Amazon 29 December 2025 - 17 January 2026

Amazon Pharmacy said on Friday it now offers Novo Nordisk’s Wegovy weight-loss pill through insurance plans and a cash-pay option, with uninsured customers paying from $149 a month and some commercially insured customers paying $25 for a one-month supply. Amazon said it will add the pill to its pharmacy kiosks in the coming weeks and is working with telehealth firms including WeightWatchers, Wheel and 9amHealth; Novo has said the pill will also be available through CVS, Costco and other telehealth services such as Ro, LifeMD and GoodRx. The U.S. FDA approved the once-daily semaglutide pill in December; semaglutide is the active ingredient in injectable Wegovy and diabetes drug Ozempic, and Reuters said the pill’s success is tied to cash-paying consumers who cannot get coverage. That shift matters because obesity drugs have mostly been sold through insurers, with list prices and rebates doing the messy work in the background. A simple “pay cash, get the pill” offer, pushed through a major retail channel, tests how much demand sits outside the usual reimbursement system — and how fast drugmakers will have to adjust.